Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

What EU Governments Need To Do About Access To Affordable Medicines

Executive Summary

In a wide-ranging discussion at the recent European Health Forum Gastein, policy makers explored big-picture challenges and ideas of what governments should do to ensure access to increasingly expensive medicines as pressures grow on national health care systems.

You may also be interested in...



Put Yourself In The CEO’s Shoes: Audience Makes Drug Pricing And Investment Decisions At EHFG

A pricing simulation exercise at the recent EHFG conference gave delegates an idea of the multiple factors that have to be taken into account when setting the price of a new drug for a rare disease – and deciding which candidate molecules are worth investing in.

Are We Getting The Medicines We Need? Speakers Ask At European Health Forum Gastein

Speakers at the recent European Health Forum Gastein conference in Austria claimed that many new drugs don’t really bring a meaningful clinical benefit, and that new ways are needed to assess the value of innovation.

Is Europe’s BeNeLuxA Coalition Moving Too Fast?

The BeNeLuxA initiative for improving access to medicines could soon include more countries, but much about the collaboration remains opaque for the pharmaceutical industry. Lawyer Koosje van Lessen Kloeke says constructive dialogue between the initiative and industry would benefit the collaboration.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

PS121742

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel